Generation and characterization of a protective monoclonal antibody to pseudomonas aeruginosa PcrV

Journal of Infectious Diseases

Volumn 186, Issue 1, 2002, Pages 64-73

  Frank, Dara W ^a   Vallis, Amy ^a   Wiener Kronish, Jeanine P ^b,c   Roy Burman, Arup ^b   Spack, Edward G ^d   Mullaney, Brian P ^b,e   Megdoud, Mehdi ^b   Marks, James D ^b   Fritz, Robert ^a   Sawa, Teiji ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d InterMune   (United States)

^e Myriad Genetic Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; BACTERIAL VIRULENCE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CYTOSOL; EPITOPE MAPPING; GRAM NEGATIVE BACTERIUM; INFECTION; LUNG INJURY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEPSIS;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; DISEASE MODELS, ANIMAL; EPITOPE MAPPING; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MICE; MICE, INBRED BALB C; PORE FORMING CYTOTOXIC PROTEINS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SEPSIS;

EID: 0036642461     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/341069     Document Type: Article

References (33)

1. Antibody-based therapies for emerging infectious diseases
2. "Serum therapy" revisited: Animal models of infection and the development of passive antibody therapy
3. Pseudomonas aeruginosa
4. Microbial pathogenesis in cystic fibrosis: Mucoid Pseudomonas aeruginosa and Burkholderia cepacia
5. Nosocomial pneumonia in mechanically ventilated adult patients: Epidemiology and prevention in 1996
6. Ventilator-associated pneumonia: Failure to respond to antibiotics therapy
7. Exoproduct secretions of Pseudomonas aeruginosa strains influence severity of alveolar epithelial injury
8. Identification of type III secreted products of the Pseudomonas aeruginosa exoenzyme S regulon
9. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury
10. In vitro cellular toxicity predicts Pseudomonas aeruginosa virulence in lung infections
11. Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury
12. Type-III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections
13. ExoT of cytotoxic Pseudomonas aeruginosa prevents uptake by corneal epithelial cells
14. Rho GTPase acivity modulates Pseudomonas aeruginosa internalization by epithelial cells
15. The exoenzyme S regulon of Pseudomonas aeruginosa
16. The basis of virulence in Pasteurella pestis: Antigen determining virulence
17. The effects of loss of different virulence determinants on the virulence and immunogenicity of strains of Pasteurella pestis
18. Biosynthesis and purification of V and W antigens in Pasteurella pestis
19. Role of V antigen in promoting virulence and immunity in Yersiniae
20. Passive immunity to Yersiniae mediated by anti-recombinant V-antigen and protein A-V antigen fusion peptide
21. Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization
22. Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague
23. Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis
24. 2in sepsis associated with Pseudomonas aeruginosa
25. Production and characterization of monoclonal antibodies to Bordetella pertussis antigens
26. Epitope mapping of neutralizing Botulinum neurotoxin A antibodies by phage display
27. Efficient construction of a large nonimmune phage antibody library: The production of high-affinity human single-chain antibodies to protein antigens
28. Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection
29. In vitro and in vivo characterization of a human anti-c-erbB-2 single-chain Fv isolated from a filamentous phage antibody library
30. Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity
31. Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen
32. Virulence role of V antigen of Yersinia pestis at the bacterial surface
33. The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation